100 VANGUARD BOULEVARD,
MALVERN , PA, 19355
MALVERN , PA, 19355
Summary
The fund seeks capital appreciation in the long term by investing in companies across any size in the United States.
The investment process starts with a list of companies in the benchmark index and focuses on companies that have prospects for rapid earnings growth.
Next, the research team utilizes fundamental research to identify stocks that are expected to outperform the market over a three- to five-year time horizon.
MoreLink
Directors
Dec 13, 2023- Mark Loughridge
- Andre F. Perold
- Emerson U. Fullwood
- Scott C. Malpass
- Mortimer J. Buckley
- Tara Bunch
- Grant Reid
- David Thomas
- Peter F. Volanakis
- Sarah Bloom Raskin
- F. Joseph Loughrey
- Deanna Mulligan
Chief Compliance Officer
- Jacqueline Angell
Fund Manager(s)
- Joel Fried
- Theo Kolokotrones
- Alfred Mordecai
- M. Ansari
- James Marchetti
Price
- 52-Week High/Low
- $213.71 - $182.29
- Turnover
- 6.3%
- Expense Ratio
- 0.36%
Company Name |
Holding |
| Amgen Inc | 2.89 % |
| Microsoft Corp | 2.69 % |
| Biogen Inc | 2.37 % |
| BioMarin Pharmaceutical Inc | 1.97 % |
| Alphabet Inc | 1.7 % |
| AECOM | 1.56 % |
| Raymond James Financial Inc | 1.56 % |
| Adobe Inc | 1.43 % |
| TJX Cos Inc/The | 1.27 % |
| Tesla Inc | 1.25 % |
| More | 1.25 % |
Documents
Performance
YTD
-
3 Year
5.34%
5 Year
57.5%
Best
49.03%
2009
Worst
-28%
2002
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 9.1% | 7% | -6.5% | 20.6% | -20.8% | 12.6% | 1.7% | 8.4% | -3.2% |
| Q2 | - | -4.4% | 6.9% | -14% | 8.7% | 22.2% | -0.2% | 5.9% | 6.6% | -1.4% |
| Q3 | - | - | 0.5% | -5.8% | -12.1% | -0.7% | -1.9% | 8.7% | 5.4% | 12.1% |
| Q4 | - | - | 7.1% | -0.3% | 5% | 5.5% | 6.1% | -15.7% | 5.6% | 3.4% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -0.2% | 5.4% | 3.7% | -3.4% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 5% | 23% | -25% | 9% | 13% | 20% | -4% | 29% | 0% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| VHCAX | - | 5% | 23% | -25% | 9% | 13% | 20% | -4% | 29% | - |
| Russell 3000 | - | - | - | -29% | 25% | 37% | 34% | -3% | 28% | 6% |
| Alpha | - | 5% | 23% | 4% | -16% | -24% | -15% | -0% | 1% | - |